WHO backs wider use of weight-loss medicines, calling obesity a …
12 hours ago · The UN World Health Organization (WHO) has issued its first guideline on the use of a new class of weight-loss medicines, marking a significant shift in global health policy as …
WHO issues global guideline on the use of GLP-1 medicines in …
14 hours ago · To address the growing global health challenge of obesity, which affects more than 1 billion people, WHO has released its first guideline on the use of Glucagon-Like Peptide-1 …
World Health Organization recommends GLP-1s amid obesity …
15 hours ago · The first conditional recommendation advises the use of GLP-1 drugs by adults, except pregnant women, for long-term obesity treatment, while the second suggests …
World Health Organization issues first-ever guidelines for use of GLP-1 …
16 hours ago · The World Health Organization on Monday released new guidance on GLP-1 medications for adults with obesity, recommending their long-term, continuous use when …
WHO Recommends GLP-1 Drugs for Obesity - TODAY
14 hours ago · The World Health Organization on Monday recommended GLP-1 drugs as a tool to manage obesity in adults, marking a shift in the way the U.N. agency has historically framed …
WHO backs use of GLP-1 therapies for obesity, warns access will …
14 hours ago · The World Health Organization issued its first guideline on the use of GLP-1 drugs for obesity, conditionally recommending them as part of long-term treatment.
WHO issues guidance on GLP-1 drugs for obesity - MSN
1 day ago · The World Health Organization issued new guidelines recommending the use of GLP-1 drugs for adults with obesity and called for action on manufacturing and affordability.
WHO Unveils GLP-1 Guidelines | Scientific American
16 hours ago · New World Health Organization guidelines for GLP-1 weight-loss drugs state that “intensive behavioral therapy” should be combined with these revolutionizing medications for …
WHO guideline on the use of glucagon-like peptide-1 (GLP-1) …
12 hours ago · This guideline offers evidence-informed recommendations on the use of glucagon-like peptide-1 (GLP-1) receptor agonists and glucose-dependent insulinotropic polypeptides …
WHO Recommends GLP-1s for Obesity Management in New …
1 day ago · The new World Health Organization guideline recognizes obesity as a chronic disease that can be treated with drug therapy as a co-intervention in a multimodal program.